Addition of trastuzumab may potentially equalize disease-free survival outcomes among obese and normal-weight patients
Thursday, December 8, 2011 - 11:31
in Health & Medicine
SAN ANTONIO -- A large, multicenter, randomized study has shown that obese patients with HER2-positive breast cancer have larger tumors, increased lymph node involvement and, when not treated with...